TY - JOUR
T1 - Virus–Host Interplay Between Poly (ADP-Ribose) Polymerase 1 and Oncogenic Gammaherpesviruses
AU - Chung, Woo Chang
AU - Song, Moon Jung
N1 - Funding Information:
This work was supported by the National Research Foundation of Korea (NRF) grants, the Bio and Medical Technology Development Program, and the Basic Research Laboratory Program of NRF funded by the Korea government
Funding Information:
This work was supported by the National Research Foundation of Korea (NRF) grants, the Bio and Medical Technology Development Program, and the Basic Research Laboratory Program of NRF funded by the Korea government (MSIT) (Nos. 2020R1A2C2013827, 2021M3A9I2080487, and 2020R1A4A1018019). W-CC was supported, in part, by a postdoctoral research grant funded by MSIT (No. NRF2019R1A6A3A01093571).
Publisher Copyright:
Copyright © 2022 Chung and Song.
PY - 2022/1/14
Y1 - 2022/1/14
N2 - The gammaherpesviruses, include the Epstein–Barr virus, Kaposi’s sarcoma-associated herpesvirus, and murine gammaherpesvirus 68. They establish latent infection in the B lymphocytes and are associated with various lymphoproliferative diseases and tumors. The poly (ADP-ribose) polymerase-1 (PARP1), also called ADP-ribosyltransferase diphtheria-toxin-like 1 (ARTD1) is a nuclear enzyme that catalyzes the transfer of the ADP-ribose moiety to its target proteins and participates in important cellular activities, such as the DNA-damage response, cell death, transcription, chromatin remodeling, and inflammation. In gammaherpesvirus infection, PARP1 acts as a key regulator of the virus life cycle: lytic replication and latency. These viruses also develop various strategies to regulate PARP1, facilitating their replication. This review summarizes the roles of PARP1 in the viral life cycle as well as the viral modulation of host PARP1 activity and discusses the implications. Understanding the interactions between the PARP1 and oncogenic gammaherpesviruses may lead to the identification of effective therapeutic targets for the associated diseases.
AB - The gammaherpesviruses, include the Epstein–Barr virus, Kaposi’s sarcoma-associated herpesvirus, and murine gammaherpesvirus 68. They establish latent infection in the B lymphocytes and are associated with various lymphoproliferative diseases and tumors. The poly (ADP-ribose) polymerase-1 (PARP1), also called ADP-ribosyltransferase diphtheria-toxin-like 1 (ARTD1) is a nuclear enzyme that catalyzes the transfer of the ADP-ribose moiety to its target proteins and participates in important cellular activities, such as the DNA-damage response, cell death, transcription, chromatin remodeling, and inflammation. In gammaherpesvirus infection, PARP1 acts as a key regulator of the virus life cycle: lytic replication and latency. These viruses also develop various strategies to regulate PARP1, facilitating their replication. This review summarizes the roles of PARP1 in the viral life cycle as well as the viral modulation of host PARP1 activity and discusses the implications. Understanding the interactions between the PARP1 and oncogenic gammaherpesviruses may lead to the identification of effective therapeutic targets for the associated diseases.
KW - ADP-ribosyltransferase diphtheria-toxin-like 1 (ARTD1)
KW - Epstein-Barr virus (EBV)
KW - Kaposi’s sarcoma-associated herpesvirus (KSHV)
KW - gammaherpesvirus replication
KW - murine gammaherpesvirus 68 (MHV-68)
KW - poly (ADP-ribose) polymerase 1 (PARP1)
KW - virus-host interaction
UR - http://www.scopus.com/inward/record.url?scp=85123959201&partnerID=8YFLogxK
U2 - 10.3389/fmicb.2021.811671
DO - 10.3389/fmicb.2021.811671
M3 - Review article
AN - SCOPUS:85123959201
SN - 1664-302X
VL - 12
JO - Frontiers in Microbiology
JF - Frontiers in Microbiology
M1 - 811671
ER -